Article Versions Notes

Kim SB, Yang C-E, Jeong Y, Yu M, Choi W-S, Lim J-Y, Jeon Y. Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma. Cancers. 2023; 15(18):4472. https://doi.org/10.3390/cancers15184472

Kim, Se Been, Chae-Eun Yang, Yurim Jeong, Minseo Yu, Wan-Su Choi, Jung-Yeon Lim, and Youngwoo Jeon. 2023. "Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma" Cancers 15, no. 18: 4472. https://doi.org/10.3390/cancers15184472

Kim, S. B., Yang, C.-E., Jeong, Y., Yu, M., Choi, W.-S., Lim, J.-Y., & Jeon, Y. (2023). Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma. Cancers, 15(18), 4472. https://doi.org/10.3390/cancers15184472